cells; and (2) the potential of MBG453 to impact the autocrine feedback loop of TIM-
3/Galectin-9.
Ethics Approval : The human tissue used in these studies was under the Novartis Institutes of
BioMedical Research Ethics Board IRB, Approval Number 201252867.
